The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune response and adverse events to influenza vaccine in cancer patients undergoing PD-1 blockade.
 
Heinz Philipp Laubli
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Cathrin Balmelli
No Relationships to Disclose
 
Lukas Kaufmann
No Relationships to Disclose
 
Michal Stanczak
No Relationships to Disclose
 
Mohammedyaseen Syedbasha
No Relationships to Disclose
 
Dominik Vogt
No Relationships to Disclose
 
Beat Mueller
No Relationships to Disclose
 
Oliver Gautschi
No Relationships to Disclose
 
Frank Stenner
No Relationships to Disclose
 
Alfred Zippelius
No Relationships to Disclose
 
Adrian Egli
No Relationships to Disclose
 
Sacha Rothschild
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Lilly; Roche Pharma AG